Adverum Biotechnologies, Inc. Gains 34.51%

Mon, Feb 05, 2024 at 07:32 PM
Adverum Biotechnologies, Inc. Gains 34.51%

Adverum Biotechnologies, Inc. (ADVM:NASDAQ) soared at $1.91, a gain of 34.5%. On Mon, Feb 05, 2024, ADVM:NASDAQ touched a New 2-Week High of $1.91. The stock got featured on our News Catalysts scanner on Mon, Feb 05, 2024 at 10:05 AM in the 'BIOTECH' category. From Mon, Jan 22, 2024, the stock recorded 60.00% Up Days and 63.64% Green Days

About Adverum Biotechnologies, Inc. (ADVM:NASDAQ)

Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.